One Way Ventures
VC Fund
Boston, United States
One Way Ventures is a seed-stage fund that invests in immigrant tech founders.
- Total investments:
- 126
- Last investment:
- Lead investor:
- 18%
- Fund size:
- $58M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries One Way Ventures invests in
Stages One Way Ventures invests in
Countries One Way Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.9M–$10M
- Pre-Seed
- $500k–$2.7M
- Series A
- $6M–$15M
Investment Focus
Industry
- Software 22 (17%)
- Artificial Intelligence 19 (15%)
- Information Technology 12 (10%)
- FinTech 10 (8%)
- Health Care 10 (8%)
Stage
- Seed 56 (44%)
- Series A 17 (13%)
- Pre-Seed 15 (12%)
- Series B 8 (6%)
- Funding Round 8 (6%)
Country
- United States 66 (52%)
- Canada 5 (4%)
- Switzerland 2 (2%)
- France 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Semyon Dukach
Founding Partner
|
Founding Partner | Total investments: 52 | Find email | |
Alissa Carroll
Investment Analyst
|
Investment Analyst | Total investments: 0 | Find email | |
Eugene Malobrodsky
General Partner
|
General Partner | Total investments: 0 | Find email | |
Joe Zhou
Limited Partner
|
Limited Partner | Total investments: 6 | Find email | |
Lex Zhao
Partner
|
Partner | Total investments: 11 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Debbie
|
Points for the 99%. Get paid to pay off your debt and save. Debbie partners with mission-aligned financial institutions to acquire and engage young consumers by rewarding them for positive financial habits. | $5.3M / Seed / Apr 13, 2026 | |
|
Debbie
|
Points for the 99%. Get paid to pay off your debt and save. Debbie partners with mission-aligned financial institutions to acquire and engage young consumers by rewarding them for positive financial habits. | $5.3M / Seed / Apr 13, 2026 | |
ImmuneBridge
|
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source. | $7.7M / Seed / Mar 23, 2026 | |
Billdr
|
Billdr is an AI-native construction management platform for general contractors across North America, covering estimating, scheduling, job costing, invoicing, and client communication.Billdr brings your whole business under one roof, with an AI team built in: Bob, your AI project copilot, monitors every job in real time and flags risks beforethey become problems. Bruno, your AI estimator, builds accurate quotes in minutes from your price book. Send $100K+ quotes in 30 minutes or less. Billie, your AI receptionist (coming soon), will qualify leads, book calls, and follow up with prospects 24/7.Trusted by contractors managing $2B+ in projects across the US and Canada. | $3.2M / Seed / Jan 26, 2026 | |
Deduction
|
Deduction is a tax firm that uses AI and the tax agent tool Taylor(CPAI) to simplify and improve tax filing. | $2.8M / Pre-Seed / Nov 14, 2025 | |
Provision
|
Provision is automating construction with AI. | $7M / Seed / Oct 15, 2025 | |
Qashio
|
Qashio is a spend management platform that allows people to monitor costs, make payments with app credit cards, and handle payables. Founded in 2021 and is based in Dubai. | $19.8M / May 27, 2025 | |
|
Qashio
|
Qashio is a spend management platform that allows people to monitor costs, make payments with app credit cards, and handle payables. Founded in 2021 and is based in Dubai. | $19.8M / May 27, 2025 | |
|
Debbie
|
Points for the 99%. Get paid to pay off your debt and save. Debbie partners with mission-aligned financial institutions to acquire and engage young consumers by rewarding them for positive financial habits. | $2.8M / Seed / Jan 08, 2025 | |
Impilo
|
Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application programming interface for handling purchases, logistics, and configuration, allowing hospitals and healthcareorganizations to manage their digital health remote patient monitoring devices and supplies. | $11.5M / Series A / Nov 14, 2024 | |
| See all 126 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does One Way Ventures invest in?
One Way Ventures invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Seed and Series A stage. Most of the 126 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is One Way Ventures's check size?
One Way Ventures typically joins rounds of $1.9M–$10M at Seed, $500k–$2.7M at Pre-Seed and $6M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds One Way Ventures participates in.
How do I contact One Way Ventures?
Public channels for One Way Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at One Way Ventures?
The team at One Way Ventures includes Semyon Dukach (Founding Partner), Alissa Carroll (Investment Analyst) and Eugene Malobrodsky (General Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
